AL-Amyloidosis
from OrphaChat — a Rare Disease Podcast Hosted by RCH
These sources provide a comprehensive overview of systemic amyloidosis, a group of rare disorders where misfolded proteins accumulate as fibrils in vital organs. The texts detail several variations, including AL (light-chain) and ATTR (transthyretin) types, which frequently lead to failure of the heart, kidneys, and liver. Diagnostic methods described involve biomarkers like troponin and NT-proBNP, alongside advanced scintigraphy imaging and tissue biopsies. Management focuses on type-specific therapies, such as the Dara-CyBorD regimen and stem cell transplants, to stop protein production and extend survival. The documentation also emphasises the necessity of supportive care to manage symptoms like orthostatic hypotension and nutritional deficiencies. Finally, researchers present staging systems that use organ function metrics to predict patient outcomes and monitor treatment success.
Embed this episode
No transcript yet.